Literature DB >> 27625296

Masked hypoglycemia in pregnancy.

Dukhabandhu Naik1, Asha Hesarghatta Shyamasunder1, Mahesh Doddabelavangala Mruthyunjaya1, Rita Gupta Patil1, Thomas Vizhalil Paul1, Flory Christina1, Mercy Inbakumari1, Ruby Jose2, Jessie Lionel2, Annie Regi2, P Visalakshi Jeyaseelan3, Nihal Thomas1.   

Abstract

BACKGROUND: Hypoglycemia is a major hindrance for optimal glycemic control in women with gestational diabetes mellitus (GDM) on insulin. In the present study, masked hypoglycemia (glucose <2.77mmol/L for ≥30 min) was estimated in pregnant women using a continuous glucose monitoring (CGM) system.
METHODS: Twenty pregnant women with GDM on insulin (cases) and 10 age-matched euglycemic pregnant women (controls) between 24 and 36 weeks gestation were recruited. Both groups performed self-monitoring of blood glucose (SMBG) and underwent CGM for 72 h to assess masked hypoglycemia. Masked hypoglycemic episodes were further stratified into two groups based on interstitial glucose (2.28-2.77 and ≤2.22 mmol/L).
RESULTS: Masked hypoglycemia was recorded in 35% (7/20) of cases and 40% (4/10) of controls using CGM, with an average of 1.28 and 1.25 episodes per subject, respectively. Time spent at glucose levels between 2.28 and 2.77 mmol/L did not differ between the two groups (mean 114 vs 90 min; P = 0.617), but cases spent a longer time with glucose ≤2.2 mmol/L. Babies born to women with GDM were significantly lighter than those born to controls (2860 vs 3290 g; P = 0.012). There was no significant difference in birth weight within the groups among babies born to women with or without hypoglycemia.
CONCLUSION: Euglycemic pregnant women and those with GDM on insulin had masked hypoglycemia. Masked hypoglycemia was not associated with adverse maternal or fetal outcomes. Therefore, low glucose levels in the hypoglycemic range may represent a physiologic adaptation in pregnancy. This response is exaggerated in women with GDM on insulin.
© 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  continuous glucose monitoring; gestational diabetes mellitus; masked hypoglycemia; 动态血糖监测; 妊娠糖尿病; 隐性低血糖

Mesh:

Substances:

Year:  2016        PMID: 27625296     DOI: 10.1111/1753-0407.12485

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  7 in total

1.  Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes.

Authors:  Song-Ying Shen; Justina Žurauskienė; Dong-Mei Wei; Nian-Nian Chen; Jin-Hua Lu; Ya-Shu Kuang; Hui-Hui Liu; Jean-Baptiste Cazier; Xiu Qiu
Journal:  Endocrine       Date:  2021-06-14       Impact factor: 3.633

Review 2.  CGM, Pregnancy, and Remote Monitoring.

Authors:  Sarit Polsky; Rachel Garcetti
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

3.  Glycaemic profile in the second and third trimesters of normal pregnancy compared to non-pregnant adult females.

Authors:  Aruna Nigam; Neha Varun; Sumedha Sharma; Y P Munjal; Anupam Prakash
Journal:  Obstet Med       Date:  2019-02-02

4.  Application and Utility of Continuous Glucose Monitoring in Pregnancy: A Systematic Review.

Authors:  Qi Yu; Izzuddin M Aris; Kok Hian Tan; Ling-Jun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-11       Impact factor: 5.555

5.  Flash glucose monitoring in gestational diabetes mellitus: study protocol for a randomised controlled trial.

Authors:  Agata Majewska; Paweł Stanirowski; Mirosław Wielgoś; Dorota Bomba-Opoń
Journal:  BMJ Open       Date:  2021-03-02       Impact factor: 2.692

6.  Prediction of low birth weight with hypoglycemia in glucose tolerance test.

Authors:  Flavio Hernández-Castro; Anaís Berlanga-Garza; Mayela Diamantina Cruz-Gutiérrez; Juan Antonio Soria-López; Gabriel Edgar Villagómez-Martínez; Iván Vladimir Dávila-Escamilla
Journal:  Rev Saude Publica       Date:  2021-05-17       Impact factor: 2.106

7.  Factors Influencing Variations in Hospitalization for Diabetes with Hypoglycemia.

Authors:  Waleed Kattan; Thomas T H Wan
Journal:  J Clin Med       Date:  2018-10-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.